Suscribirse

Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study - 18/03/25

Doi : 10.1016/j.amjmed.2024.09.006 
Patrizia Pasculli, MD a, , Maria Antonella Zingaropoli, PhD a, Federica Dominelli, PhD a, Angelo Giuseppe Solimini, PhD, MD a, Giorgio Maria Masci, MD b, Lucia Ilaria Birtolo, MD c, Lara Pasquariello, MD d, Filippo Paribeni, MD e, Franco Iafrate, MD b, Valeria Panebianco, MD b, Gioacchino Galardo, MD, PhD f, Massimo Mancone, MD, PhD c, Carlo Catalano, MD b, Francesco Pugliese, MD e, Paolo Palange, MD d, Claudio Maria Mastroianni, MD, PhD a, Maria Rosa Ciardi, MD a
a Department of Public Health and Infectious Diseases, Rome, Italy 
b Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Rome, Italy 
c Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy 
d Department of Public Health and Infectious Diseases, Division of Pulmonary Medicine, Policlinico Umberto I Hospital, Rome, Italy 
e Department of Specialist Surgery and Organ Transplantation "Paride Stefanini", Policlinico Umberto I, Rome, Italy 
f Medical Emergency Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy 

Requests for reprints should be addressed to Patrizia Pasculli, MD, Department of Public Health and Infectious Diseases, Sapienza University of Rome 00185, Rome, Italy.Department of Public Health and Infectious DiseasesSapienza University of RomeRome00185Italy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

The long-term symptomatology of COVID-19 has yet to be comprehensively described. The aim of the study was to describe persistent COVID-19 symptoms in a cohort of hospitalized and home-isolated patients.

Methods

A retrospective cohort study was conducted on long COVID patients. Long COVID symptoms were identified, and patients were divided into hospitalized (in-patients) and home-isolated (out-patients), as well as according to the number of symptoms. Patients were examined by a multidisciplinary medical team. Blood tests, high resolution chest computed tomography (CT), and physical and infectious examinations were performed. Finally, in-patients were evaluated at 2 time-points: on hospital admission (T0) and 3 months after discharge (Tpost).

Results

There were 364 COVID-19 patients enrolled; 82% of patients reported one or more symptoms. The most reported symptom was fatigue. Chest CT showed alteration in 76% of patients, and pulmonary function alterations were observed in 44.7% of patients. A higher risk of presenting at least one symptom was seen in patients treated with corticosteroid, and a higher risk of presenting chest CT residual lesion was observed in hospitalized patients and in patients that received hydroxychloroquine treatment. Moreover, a higher risk of altered pulmonary function was observed in older patients.

Conclusion

Long-term sequelae are present in a remarkable number of long COVID patients and pose a new challenge to the health care system to identify long-lasting effects and improve patients’ well-being. Multidisciplinary teams are crucial to develop preventive measures, and clinical management strategies.

El texto completo de este artículo está disponible en PDF.

Keywords : Long COVID, PASC, Radiological long-term sequelae, Retrospective cohort study, SARS-CoV-2 infection


Esquema


 Funding: This study was not supported by funds.
 Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
 Authorship: All authors had access to the data and played a role in writing the manuscript. PP: Writing – original draft, review, and editing, Investigation, Data curation, Conceptualization; MAZ: Writing – original draft, review, and editing, Methodology, Investigation, Conceptualization; FD: Writing – original draft, Investigation; AGS: Writing – original draft, Investigation, Formal analysis, Data curation; GMM: Methodology, Investigation, Data curation; LIB: Methodology, Investigation, Data curation; LP: Methodology, Investigation, Data curation; FP: Methodology, Investigation, Data curation; FI: Methodology, Investigation, Data curation; VP: Methodology, Investigation, Data curation; GG: Validation, Methodology, Investigation, Data curation; MM: Supervision, Investigation; CC: Supervision, Resources; FP: Validation, Resources; PP: Supervision, Resources, Methodology; CMM: Visualization, Validation, Supervision, Resources; MRC: Writing – review & editing, Visualization, Validation, Supervision, Project administration.


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 138 - N° 4

P. 721-731 - avril 2025 Regresar al número
Artículo precedente Artículo precedente
  • Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort
  • Mitsuaki Sawano, Yilun Wu, Rishi M. Shah, Tianna Zhou, Adith S. Arun, Pavan Khosla, Shayaan Kaleem, Anushree Vashist, Bornali Bhattacharjee, Qinglan Ding, Yuan Lu, César Caraballo, Frederick Warner, Chenxi Huang, Jeph Herrin, David Putrino, Teresa Michelsen, Liza Fisher, Cynthia Adinig, Akiko Iwasaki, Harlan M. Krumholz
| Artículo siguiente Artículo siguiente
  • Adult Outpatients with Long COVID Infected with SARS-CoV-2 Omicron Variant. Part 1: Oral Microbiota Alterations
  • Jianchao Xu, Di Wu, Jie Yang, Yinuo Zhao, Xuzhao Liu, Yingying Chang, Yao Tang, Feng Sun, Yubin Zhao

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.